Logo Geneseeq
  • Products
    • Solid Tumors
      • Pan-Cancer
      • Cancer Type-Specific
      • Minimal Residual Disease
    • Hematologic Malignancies
      • Pan-Cancer
      • Cancer Type-Specific
    • Cancer Early Detection
    • Hereditary Cancers
  • Services
    • Central Lab Testing
    • Local Testing Solutions
      • IVD Kit Solutions
      • RUO Kit Solutions
    • Research Services
      • DNA Sequencing
      • RNA Sequencing
  • Technology
    • Our Technology
    • Publications
  • Partnerships
  • About Us
    • What is Precision Oncology?
    • Our Company
    • Our Team
    • Certificates & Accreditation
  • News
    • Newsroom
    • Geneseeq Blogs
  • Join Us
  • Contact Us
  • Search

July 3, 2024

Geneseeq partners with Jiangsu Vcare PharmaTech to develop a CDx for NTRK inhibitor in China.

by GENESEEQ

May 14, 2024

Geneseeq AT ASCO 2024

by GENESEEQ

March 6, 2024

Geneseeq to Showcase Twelve Studies at 2024 American Association for Cancer Research (AACR) Annual Meeting

by GENESEEQ

October 17, 2023

Geneseeq to present four studies at ESMO 2023

by Geneseeq

August 29, 2023

GENESEEQ TO SHARE EIGHT COLLABORATED STUDIES AT WCLC 2023

by Geneseeq

August 22, 2023

Geneseeq Gains CE Marks for NGS-based Test Kits for Solid Tumors and Hematological Cancer

by Geneseeq

May 25, 2023

GENESEEQ TO SHOWCASE NEW FINDINGS AT ASCO 2023

by Geneseeq

May 16, 2023

Geneseeq published new research on the clinical use of circulating-free DNA fragmentomic in monitoring minimal residual disease for patients with non-small-cell lung cancer

by Geneseeq

April 13, 2023

Geneseeq co-publish with UHN on using ctDNA as a prognostic biomarker for immunotherapy

by GENESEEQ

April 11, 2023

Geneseeq to Present 13 Posters at AACR 2023

by GENESEEQ

  • 1
  • 2
  • 3
Logo Geneseeq

1-647-714-5020
1-800-362-0325
info@geneseeq.ca

Quick Links
  • Services
  • Technology
  • News
  • About Us
Connect
  • Partnerships
  • Join us
  • Contact us
Privacy
  • Privacy Policy
  • Terms of Use
Headquarters

Main Office:
Suite 1802
393 University Avenue
Toronto, Ontario, M5G 1E6
Canada

© 2026 Geneseeq Technology Inc. | A Precision Oncology Company. All rights reserved

Privacy Preference Center

Privacy Preferences

    FDA Cleared IVD kit